Tyra Bioscience's total assets for Q3 2025 were $301.85M, a decrease of -6.11% from the previous quarter. TYRA total liabilities were $21.34M for the fiscal quarter, a 10.28% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.